shortagewatch

Home / Atomoxetine / Canada

CA ATC N06BA09 · updated 2 Nov 2026

Atomoxetine shortage in Canada

Is there an Atomoxetine shortage in Canada?

Yes. As of 2 Nov 2026, 9 Atomoxetine products are reported short in Canada, the first since 2 Jun 2025. The company estimate for the return is 20 Nov 2026 (latest 1 Jan 2028). Main reason: manufacturing problem.

Also short in Germany, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden, Japan, Australia. All countries.

Affected products in Canada

CountryProductCompanySinceExpected backReason
CARIVA-ATOMOXETINE (30)LABORATOIRE RIVA INC.2 Jun 2025not givenIncreased demand
Demand increase for the drug
CARIVA-ATOMOXETINE (30)LABORATOIRE RIVA INC.13 Jun 2025not givenDistribution or logistics
Delay in shipping of the drug
CAPMS-ATOMOXETINE (3x10)PHARMASCIENCE INC15 Sep 2025not givenManufacturing problem
Disruption of the manufacture of the drug
CAPMS-ATOMOXETINE (3x10)PHARMASCIENCE INC15 Sep 2025not givenManufacturing problem
Disruption of the manufacture of the drug
CAPMS-ATOMOXETINE (3x10)PHARMASCIENCE INC15 Sep 2025not givenManufacturing problem
Disruption of the manufacture of the drug
CAJAMP ATOMOXETINE (Blister 3 x 10)JAMP PHARMA CORPORATION12 Mar 20261 Jan 2028Manufacturing problem
Disruption of the manufacture of the drug
CAJAMP ATOMOXETINE (Blister 3 x 10)JAMP PHARMA CORPORATION12 Mar 20261 Jan 2028Manufacturing problem
Disruption of the manufacture of the drug
CAJAMP ATOMOXETINE (Blister 3 x10)JAMP PHARMA CORPORATION12 Mar 20261 Jan 2028Manufacturing problem
Disruption of the manufacture of the drug
CAAPO-ATOMOXETINE (30 BLS)APOTEX INC13 Oct 202620 Nov 2026Manufacturing problem
Disruption of the manufacture of the drug

Source

Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.